The advanced cancer diagnostics market in the Middle East reached an estimated valuation of USD 1.43 billion in 2025, with robust projections targeting USD 2.51 billion by 2033. This rapid expansion is underpinned by a compound annual growth rate (CAGR) of 7.3%, driven by increasing cancer incidence, urgency for early and accurate detection, ongoing technology upgrades, and far-reaching modernization in healthcare systems across Saudi Arabia, UAE, Kuwait, Oman, Qatar, and surrounding regions.
The global point-of-care influenza diagnostics market reached approximately USD 440.47 million in 2025 and is expected to grow to USD 709.52 million by 2033, at a CAGR of 6.14% during the period from 2025 to 2033. Key growth drivers include increased prevalence and severity of seasonal and zoonotic influenza outbreaks, rapid adoption of decentralized testing, technological innovation in diagnostics, and integration with telehealth and home-based healthcare solutions.
The Latin America energy-based aesthetic devices market was valued at approximately USD 378.5 million in 2025 and is expected to grow to USD 638.0 million by 2033, registering a compound annual growth rate (CAGR) of 6.7% between 2025 and 2033.
The Middle East & Africa (MEA) wound wash market was valued at approximately USD 2.26 billion in 2025, expected to reach USD 3.76 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.59% from 2025 to 2033. Market expansion is attributed to increasing prevalence of chronic and acute wounds like diabetic ulcers and surgical injuries, alongside improved healthcare infrastructure and accessibility across the region.
The U.S. surgical sutures market was valued at approximately USD 1.89 billion in 2025 and is anticipated to grow to USD 2.21 billion by 2030, registering a compound annual growth rate (CAGR) of 3.18% between 2025 and 2030. Growth is driven by increasing surgical procedures, including both elective and emergency surgeries, alongside expanding adoption of minimally invasive techniques.
The U.S. orthodontic headgear market was valued at approximately USD 368.43 million in 2024 and is projected to reach USD 591.80 million by 2033, growing at a compound annual growth rate (CAGR) of 5.46% from 2025 to 2033.
The Australia & New Zealand healthcare contract research organizations (CROs) market was valued at approximately USD 1.45 billion in 2025 and is projected to reach USD 3.35 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.02% from 2025 to 2033. Market growth is supported by strong regulatory and ethical frameworks, government incentives, investment in research and development (R&D), advanced infrastructure, and a diverse patient population.
The global hemorrhoids treatment market was valued at approximately USD 818.82 million in 2025 and is expected to reach USD 1,465.28 million by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033. The market growth is driven by the increasing prevalence of hemorrhoidal disorders, influenced by sedentary lifestyles, poor dietary habits, rising obesity levels, and aging populations leading to reduced tissue elasticity.
The global beef cattle health market was valued at approximately USD 6.23 billion in 2025 and is projected to reach USD 12.22 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2033. Market growth is driven by the rising incidence of infectious and parasitic diseases such as bovine respiratory disease and New World screwworm, which adversely affect herd productivity and cattle health.
The global acute pancreatitis market was valued at approximately USD 3.57 billion in 2025 and is anticipated to grow to USD 5.60 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033. The market expansion is driven by increased awareness of pancreatic health, a rising incidence of lifestyle-related disorders, and advancements in diagnostic and therapeutic technologies.
